By Lisa Uhlman ( August 6, 2012, 5:17 PM EDT) -- Women's health care company K-V Pharmaceutical Co. filed for Chapter 11 protection Saturday in New York, citing its inability to realize full value on its biggest product, preterm-birth drug Makena, and a $45 million milestone payment due on a related rights agreement with Hologic Inc....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.